Results 251 to 260 of about 548,748 (356)

Two New Epimeric Decalinoylspirotetramic Acid Derivatives From the Acanthus ilicifolius ‐Derived Fungus Trichoderma sp. RSF‐1 [PDF]

Jiaojiao Li, Hui Liu, Guangshan Yao, Yao‐Yao Zheng, Yahui Zhang, Pingyuan Wang, Chang‐Yun Wang   +6 more
openalex   +1 more source

Efficacy of Telitacicept in Childhood‐Onset Systemic Lupus Erythematosus: A Prospective Multicenter Cohort Study With Inverse Probability of Treatment Weighting –Adjusted Comparison to a Historical Control Group Treated With Belimumab

Arthritis &Rheumatology, EarlyView.
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo, Shu Su, Jingyue Liu, Junyu Lin, Jin Song, Zongwen Chen, Yuanyuan Peng, Lijun Jiang, Meng Jia, Li Wang, Xinhui Jiang, Wei Zhang, Zanhua Rong, Bo Zhao, Yajun Wang, Xuemei Tang   +15 more
wiley   +1 more source

Sustainable recovery of a chitin–glucan complex–protein biocomposite from yeast biomass using biocompatible ionic liquids

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Chitin–glucan complex (CGC) is typically extracted from fungal or yeast biomass using harsh alkaline treatments that not only generate high‐salt, organic‐rich effluents, but also negatively impact the structural and functional properties of the recovered copolymer, while wasting the yeast protein fraction, which is discarded.
Inês C. Ferreira, Cristiana A. V. Torres, Carlos A. M. Afonso, Luísa A. Neves, Filomena Freitas   +4 more
wiley   +1 more source

COCAINE FUNGUS. [PDF]

The Lancet, 1885
openaire   +1 more source

Bacterial Protection of Beetle-Fungus Mutualism

, 2008
Jarrod J. Scott, Dong‐Chan Oh, Mehmet Yüceer, Kier D. Klepzig, Jon Clardy, Cameron R. Currie   +5 more
openalex   +1 more source

Raw citrus by‐product valorization: unlocking the potential of biotransformation by Talaromyces amestolkiae to obtain cellulolytic enzymes and natural colorants

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Agro‐industrial by‐products can be used as valuable nutrient sources for the sustainable production of high‐value‐added compounds. The goal of this study was utilize raw citrus industrial by‐product (RCB) as a carbon source for the simultaneous production of red colorants and enzymes by the filamentous fungus Talaromyces amestolkiae under lab ...
Caio de Azevedo Lima, Heitor B. S. Bento, Flávio Pereira Picheli, Fernanda de Oliveira, Almiro Pires da Silva Neto, Danielle Biscaro Pedrolli, Fernando Masarin, Silvio Silvério da Silva, Valéria Carvalho Santos‐Ebinuma   +8 more
wiley   +1 more source

<i>Tuber</i> Inoculation Drives Rhizosphere Microbiome Assembly and Metabolic Reprogramming in <i>Corylus</i>. [PDF]

Int J Mol Sci
Wang J, Zeng NK, Zhang X.
europepmc   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Two Decades of Research on Marine-Derived <i>Alternaria</i>: Structural Diversity, Biomedical Potential, and Applications. [PDF]

Mar Drugs
Youssef DTA, Alqarni AS, Shaala LA, Bagalagel AA, Fadil SA, Omar AM, Rateb ME.   +6 more
europepmc   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source